Jensen Claus Torp 4
4 · Teladoc Health, Inc. · Filed Sep 6, 2023
Insider Transaction Report
Form 4
Jensen Claus Torp
Chief Innovation Officer
Transactions
- Exercise/Conversion
Common Stock
2023-09-01+2,043→ 17,946 total - Exercise/Conversion
Restricted Stock Units
2023-09-01−2,807→ 16,845 total→ Common Stock (2,807 underlying) - Sale
Common Stock
2023-09-05$22.89/sh−2,093$47,917→ 15,853 total - Exercise/Conversion
Restricted Stock Units
2023-09-01−2,043→ 14,307 total→ Common Stock (2,043 underlying) - Exercise/Conversion
Common Stock
2023-09-01+2,807→ 15,903 total
Footnotes (4)
- [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
- [F3]On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F4]On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.